InMode (INMD) Liabilities and Shareholders Equity (2017 - 2026)
InMode's (INMD) quarterly Liabilities and Shareholders Equity came in at $720.3 million in Q2 2026, up 1.69% year-over-year from $708.3 million in Q2 2025, and down 4.06% quarter-over-quarter from $750.8 million in Q1 2026.
Analysis
InMode (INMD) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
InMode has disclosed Liabilities and Shareholders Equity across 10 years of filings, most recently posting $720.3 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 1.69% year-over-year to $720.3 million; the TTM figure through Jun 2026 stood at $3.0 billion (down 1.67% YoY), while the FY2025 annual figure was $766.4 million, down 2.45% from the prior year.
- Liabilities and Shareholders Equity came in at $720.3 million for Q2 2026 at InMode, down from $750.8 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $891.7 million in Q1 2024 to a low of $464.5 million in Q1 2022.
- Average Liabilities and Shareholders Equity over 5 years is $723.2 million, with a median of $734.3 million recorded in 2023.
- Year-over-year, Liabilities and Shareholders Equity surged 44.17% in 2023 and declined 20.97% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $644.4 million in 2022, then jumped by 33.97% to $863.3 million in 2023, then dropped by 8.99% to $785.7 million in 2024, then declined by 2.45% to $766.4 million in 2025, then fell by 6.01% to $720.3 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $720.3 million in Q2 2026, $750.8 million in Q1 2026, and $766.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 10.74 Bn |
| 10 | InMode | 955.60 Mn | 473.48 Mn | 71.52 Mn | 720.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 720.33 Mn |
| Mar 31, 2026 | 750.84 Mn |
| Dec 31, 2025 | 766.43 Mn |
| Sep 30, 2025 | 734.61 Mn |
| Jun 30, 2025 | 708.35 Mn |
| Mar 31, 2025 | 704.74 Mn |
| Dec 31, 2024 | 785.67 Mn |
| Sep 30, 2024 | 824.03 Mn |
| Jun 30, 2024 | 859.84 Mn |
| Mar 31, 2024 | 891.74 Mn |
| Dec 31, 2023 | 863.29 Mn |
| Sep 30, 2023 | 793.53 Mn |
| Jun 30, 2023 | 734.08 Mn |
| Mar 31, 2023 | 669.61 Mn |
| Dec 31, 2022 | 644.41 Mn |
| Sep 30, 2022 | 578.98 Mn |
| Jun 30, 2022 | 523.21 Mn |
| Mar 31, 2022 | 464.47 Mn |
| Dec 31, 2021 | 478.54 Mn |
| Sep 30, 2021 | 447.66 Mn |